Login / Signup
Michaela E Sharpe
(Michaela Sharpe)
ORCID
Publication Activity (10 Years)
Years Active: 2018-2022
Publications (10 Years): 3
Top Topics
Embryonic Stem Cells
Randomized Controlled Trial
Genome Wide
Copy Number
Top Venues
Toxicologic pathology
Regenerative medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Michaela E Sharpe
,
Laura Beswick
,
Panos Kefalas
Using analogue data to substantiate long-term durability of gene therapies: a narrative review.
Regenerative medicine
17 (10) (2022)
Richard Haworth
,
Michaela E Sharpe
Accept or Reject: The Role of Immune Tolerance in the Development of Stem Cell Therapies and Possible Future Approaches.
Toxicologic pathology
49 (7) (2020)
Michaela E Sharpe
T-cell Immunotherapies and the Role of Nonclinical Assessment: The Balance between Efficacy and Pathology.
Toxicologic pathology
46 (2) (2018)